Mallinckrodt has announced to sell its Canadian drug manufacturing BioVectra Inc. to a Miami-based private equity firm, an affiliate of H.I.G. Capital for approximately USD 250 Million. The agreeme...
Daiichi Sankyo announced the submission of a New Drug Application (NDA) of DS-8201 to Japan's Ministry of Health, Labour and Welfare (MHLW). DS-8201 [fam-] trastuzumab deruxtecan), is an investigational antibody-drug conjugate (ADC) designed to deliver cytotoxic chemotherapy to cancer cells via a human epiderma...
Find MoreVertex Pharmaceuticals recently has announced the acquisition of Semma Therapeutics for USD 950 million in cash. Vertex Pharmaceuticals, aimed at creating therapies for life-threatening diseases, like cystic fibrosis, has signed a definitive agreement with Semma therapeutics, working to bring in the Healthcare ...
Find MoreHelsinn Group grants exclusive licensing rights to Blanver and Varifarma for its leading drug Pracinostat in South America. Helsinn is a Swiss biopharmaceutical company committed to producing the best solutions aimed at improving the quality of life for people with cancer. Under the terms of the agreements, ...
Find MoreFDA urges Pharma giants to increase their inclusion of men in new Breast Cancer trials The recent FDA recommendations have urged the Pharma companies for the inclusion of men in the clinical trials to test new breast cancer drugs. Men rarely develop Breast cancer. Less than 1% of men develop Breast cancer. And 1...
Find MoreZogenix pays USD 250M upfront Modis clinical drug Zogenix, a pharmaceutical company focused on advancing rare disease therapies, has collaborated with the Modis therapeutics. Modis Therapeutics is a company aiming to advance in mitochondrial biology to develop disease-modifying therapies for rare genetic diseas...
Find MoreThemis Bioscience forms an Exclusive License and Research Alliance with MSD to Develop Vaccines Themis Bioscience, a vaccine development firm, has collaborated with the MSD, a trademark company of the Merck. The agreement is an exclusive license with MSD for the discovery and development of measles vaccines to f...
Find MoreJuvenescence closes a USD 100 Million Series B round Juvenescence, a life sciences company focused on treating ageing problems, has successfully raised USD 100 Million in a Series B round. The investors who took part in the funding were Grok Ventures, the investment company of Mike Cannon-Brookes (Atlassian co-...
Find MoreEU recommends the use of Imbruvica for two new indications The Janssen Pharmaceutical has received the approval for its drug Imbruvica (ibrutinib) from the European Commission (EC). Ibrutinib is a first-in-class targeted therapy, which inhibits the function of Bruton's tyrosine kinase (BTK). Jointly developed an...
Find MoreGNA Biosolutions nets USD 13.5 Million in a Series C Funding GNA Biosolutions has secured USD 13.5 Million completing its all the rounds of financing. GNA Biosolutions GmbH, a Germany-based molecular diagnostics company has been able to successfully secure IVD-CE marking of its first point-of-care (POC) molecul...
Find MorePast decades have witnessed a shift in the focus of researchers and pharma companies towards tailori.....
Find MoreThe Union of the European countries, also known as the European Union or the EU, is more or less lik.....
Find MoreAAV Vectors are the leading viral vectors for gene delivery to treat a variety of human diseases. Ad.....
Find MoreThe pharma industry has played a crucial role in fighting against the pandemic situation by supplyin.....
Find MoreDevelopmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are cha.....
Find MoreIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.